News & Events
-
January 22, 2009
Japanese PMDA Announces First Biomarker Qualification
The unprecedented sharing of data by the industry has facilitated regulatory agencies to receive, review and approve new methods as qualified for use in drug development. The use of these new tests can now be used in laboratory research to predict the safety of experimental drugs, allowing drugs to reach the market faster and with... -
January 21, 2009
Translational Toxicology and the Work of the Predictive Safety Testing Consortium
Mattes WB, Walker EG. Translational Toxicology and the Work of the Predictive Safety Testing Consortium. Clinical Pharmacology and Therapeutics. 2009 Mar;85(3):327–30.
-
January 10, 2009
C-Path Names Respected Business Executive to Lead its Operations
Richard T. Myers, a former senior executive with engineering expertise at IBM, has been named Chief Operating Officer of the nonprofit Critical Path Institute, its founder and CEO, Dr. Ray Woosley, announced. -
November 10, 2008
C-Path is No. 7 in Reader’s Digest List of 18 Big Ideas to Fix Healthcare Now
The November 2008 issue of Reader’s Digest lists 18 big ideas to fix healthcare now and the Critical Path Insitute is listed as number 7. -
November 10, 2008
Amgen Biomarker Toolkit – Biomarker Backgrounder
Personalized Medicine: In clinical practice, personalized medicine refers to the use of new methods of molecular analysis to better manage a patient’s disease…